NCT04287049View on ClinicalTrials.gov

A Study of Standard Drugs for Mycobacterium Avium Complex

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

March 21, 2025

Study Completion Date

March 21, 2025

Conditions
Mycobacterium Avium Complex
Interventions
DRUG

Azithromycin

Azithromycin 250 mg PO daily

Trial Locations (1)

21205

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

American College of Chest Physicians

OTHER

lead

Johns Hopkins University

OTHER

NCT04287049 - A Study of Standard Drugs for Mycobacterium Avium Complex | Biotech Hunter | Biotech Hunter